Breast cancer
Open
Phase 3
This study is looking at hormone therapy before surgery to help shrink breast cancer.
It is for women who:
have a high number of oestrogen receptors on their breast cancer cells ()
need both hormone therapy and surgery
have been through the
Recruitment start: 23 August 2022
Recruitment end: 30 November 2027
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Michael Douek
NIHR Health Technology Assessment (HTA) programme
NIHR Efficacy and Mechanism Evaluation (EME) Programme
University of Oxford
University of Southampton
University of Bristol
Last reviewed: 30 Jun 2026
CRUK internal database number: 19954